Drug-drug Interaction of Acetaminophen and Roxithromycin with the Cocktail of Cytochrome P450 and Hepatotoxicity in Rats

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2020 Mar 6

PMID 32132876

Citations 3

Authors

Xiang Liu

Chen Chen

Xiaoying Zhang

Affiliations

Soon will be listed here.

Abstract

Acetaminophen (APAP) and roxithromycin (ROX) are often used in combination in clinical practice. To evaluate their drug-drug interactions (DDIs) and the hepatotoxicity of co-administration, rats were randomly separated into four groups: Control, APAP (50 mg/kg), ROX (5.5 mg/kg) and APAP-ROX (50 mg/kg and 5.5 mg/kg, respectively). The pharmacokinetic parameters between APAP and ROX were assayed by HPLC, and a cocktail method was used to evaluate the activities of cytochrome (CYP) 450. The liver microsome CYP2E1 protein was detected using Western blot. The levels of plasma parameters, mRNA levels of inflammatory factors (TNF-α, INF-γ, VCAM-1, CXCL-1 and STAT-3) and antioxidant factors (Nrf-2, GSTA, GCLC-1, HO-1 and NQO1) were determined using real-time PCR, along with the observation on histopathological changes in the liver tissue. APAP and ROX co-treatment significantly increased CYP2E1 activity, decreased CYP2D6 activity and prolonged APAP and ROX clearance. Co-treatment increased mRNA expressions of TNF-α, NQO1 and MDA while decreasing GPX and SOD levels. Histopathological evidence showed the changes of liver tissues in terms of structure, size and tight arrangement. This study confirmed that a combination of APAP and ROX inhibited APAP metabolism and that the peak concentration of ROX was delayed. The resulting high level of CYP2E1 may induce oxidative stress and cause liver damage.

Citing Articles

Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.

Kumar S, Singla B, Singh A, Thomas-Gooch S, Zhi K, Singh U Cells. 2022; 11(17).

PMID: 36078027 PMC: 9454765. DOI: 10.3390/cells11172620.

A combined metabolomics and molecular biology approach to reveal hepatic injury and underlying mechanisms after chronic l-lactate exposure in mice.

Dong M, Yi Q, Shen D, Yan J, Jiang H, Xie J Comput Struct Biotechnol J. 2022; 20:3935-3945.

PMID: 35950184 PMC: 9352416. DOI: 10.1016/j.csbj.2022.07.034.

Synthesis of OmpA Oral Nanoparticles and Evaluation of Immune Functions against the Major Etiologic Agent of Cow Mastitis.

Liu X, Sun W, Wu N, Rong N, Kang C, Jian S Vaccines (Basel). 2021; 9(3).

PMID: 33807110 PMC: 8005184. DOI: 10.3390/vaccines9030304.

References

Hedgpeth B, Missall R, Bambaci A, Smolen M, Yavuz S, Cottrell J . A Review of Bioinformatics Tools to Understand Acetaminophen-Alcohol Interaction. Medicines (Basel). 2019; 6(3). PMC: 6789846. DOI: 10.3390/medicines6030079. View

Mori K, Kumano A, Kodama T, Takiguchi S, Takano N, Kumada K . Evaluation of hepatic damage by reactive metabolites--with consideration of circadian variation of murine hepatic glutathione levels. J Toxicol Sci. 2014; 39(4):537-44. DOI: 10.2131/jts.39.537. View

Iasella C, Johnson H, Dunn M . Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic). Clin Liver Dis. 2016; 21(1):73-87. DOI: 10.1016/j.cld.2016.08.005. View

Rahman M, Kodidela S, Sinha N, Haque S, Shukla P, Rao R . Plasma exosomes exacerbate alcohol- and acetaminophen-induced toxicity via CYP2E1 pathway. Sci Rep. 2019; 9(1):6571. PMC: 6484097. DOI: 10.1038/s41598-019-43064-2. View

Valko M, Leibfritz D, Moncol J, Cronin M, Mazur M, Telser J . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2006; 39(1):44-84. DOI: 10.1016/j.biocel.2006.07.001. View

Xie W, Jiang Z, Wang J, Zhang X, Melzig M . Protective effect of hyperoside against acetaminophen (APAP) induced liver injury through enhancement of APAP clearance. Chem Biol Interact. 2016; 246:11-9. DOI: 10.1016/j.cbi.2016.01.004. View

Bjornsson E . Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010; 32(1):3-13. DOI: 10.1111/j.1365-2036.2010.04320.x. View

Schilling A, Corey R, Leonard M, Eghtesad B . Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010; 77(1):19-27. DOI: 10.3949/ccjm.77a.09084. View

Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M . Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019; 156(8):2230-2241.e11. DOI: 10.1053/j.gastro.2019.02.002. View

10.

Bell L, Chalasani N . Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009; 29(4):337-47. PMC: 2903197. DOI: 10.1055/s-0029-1240002. View

11.

Singh M, Kapoor A, Bhatnagar A . Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls. Chem Biol Interact. 2015; 234:261-73. PMC: 4414726. DOI: 10.1016/j.cbi.2014.12.028. View

12.

Du K, Ramachandran A, Jaeschke H . Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol. 2016; 10:148-156. PMC: 5065645. DOI: 10.1016/j.redox.2016.10.001. View

13.

Zhao H, Jiang Z, Chang X, Xue H, Yahefu W, Zhang X . 4-Hydroxyphenylacetic Acid Prevents Acute APAP-Induced Liver Injury by Increasing Phase II and Antioxidant Enzymes in Mice. Front Pharmacol. 2018; 9:653. PMC: 6020787. DOI: 10.3389/fphar.2018.00653. View

14.

Kakan X, Chen P, Zhang J . Clock gene mPer2 functions in diurnal variation of acetaminophen induced hepatotoxicity in mice. Exp Toxicol Pathol. 2010; 63(6):581-5. DOI: 10.1016/j.etp.2010.04.011. View

15.

Cheng Y, Liang X, Feng L, Liu D, Qin M, Liu S . Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro. Xenobiotica. 2016; 47(4):297-303. DOI: 10.1080/00498254.2016.1193262. View

16.

Jiang Z, Chen C, Wang J, Xie W, Wang M, Li X . Purple potato (Solanum tuberosum L.) anthocyanins attenuate alcohol-induced hepatic injury by enhancing antioxidant defense. J Nat Med. 2015; 70(1):45-53. DOI: 10.1007/s11418-015-0935-3. View

17.

Barman P, Mukherjee R, Prusty B, Suklabaidya S, Senapati S, Ravindran B . Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice. Cell Death Dis. 2016; 7:e2224. PMC: 4917664. DOI: 10.1038/cddis.2016.131. View

18.

Brown C, Reisfeld B, Mayeno A . Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008; 40(1):1-100. DOI: 10.1080/03602530802309742. View

19.

Watkins P, Seeff L . Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology. 2006; 43(3):618-31. DOI: 10.1002/hep.21095. View

20.

Roth R, Ganey P . Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?. J Pharmacol Exp Ther. 2009; 332(3):692-7. PMC: 2835443. DOI: 10.1124/jpet.109.162651. View